Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Qual Life Res. 2013 Mar 9;22(9):10.1007/s11136-013-0380-2. doi: 10.1007/s11136-013-0380-2

Table 5.

Patient characteristics of the two-group model

Symptom burden
Group Low (n = 42) High (n = 88) P*
n % n %
Treatment
  Radiotherapy** 23 56.10 29 33.72 .017
  Chemoradiotherapy** 18 43.90 57 66.28
Age
  < 60 years 26 61.90 35 39.77 .018
  ≥ 60 years 16 38.10 53 60.23
Sex
  Women 13 30.95 19 21.59 .247
  Men 29 69.05 69 78.41
Tumor stage
  0/I/II 32 86.49 52 62.65 .009
  III/IV 5 13.51 31 37.35
Cancer site
  Pharynx 20 48.78 42 47.73 .894
  Tongue 1 2.44 22 25.00 .002
ECOG PS
  0 36 92.31 52 60.47 .0003
  ≥ 1 3 7.69 34 39.53
Total radiation dose
  ≤ 60 Gy 30 71.43 51 58.62 .159
  > 60 Gy 12 28.57 36 41.38
*

Chi square test